开立医疗收盘上涨1.38%，滚动市盈率259.29倍，总市值130.38亿元

Group 1 - The core viewpoint of the articles highlights the financial performance and market position of Kaili Medical, indicating a significant decline in revenue and net profit in the first quarter of 2025 compared to the previous year [1][2] - As of July 1, 2023, Kaili Medical's stock price closed at 30.13 yuan, with a rolling PE ratio of 259.29 times, and a total market capitalization of 13.038 billion yuan [1] - The company operates in the medical device industry, which has an average PE ratio of 51.70 times and a median of 37.36 times, positioning Kaili Medical at the 119th rank within the industry [1][2] Group 2 - In the first quarter of 2025, the company reported an operating income of 430 million yuan, a year-on-year decrease of 10.29%, and a net profit of 8.0746 million yuan, reflecting a significant decline of 91.94% [2] - The company's gross profit margin stands at 63.19%, indicating a relatively high profitability despite the decline in revenue [2] - Kaili Medical specializes in the research, development, production, and sales of medical diagnostic and treatment equipment, with a strong focus on ultrasound diagnostic devices and other medical products [1]